Rottenstein Law Group Learns of New Study Demonstrating Possible Link Between Zoloft and Persistent

The Rottenstein Law Group, which represents clients with claims stemming from the birth defects caused by the antidepressant Zoloft, has learned of a new study confirming the possibility of a link between mothers who take selective serotonin reuptake inhibitors (SSRIs) including Zoloft and infants born with persistent pulmonary hypertension (PPHN). New York, NY (PRWEB) January 18, 2012 According to a Jan. 12 article on Yahoo! News, a new Swedish study shows that expectant mothers who take an SSRI such as Zoloft late in their pregnancies are twice as likely to give birth to a child with PP
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories